Clinical Trial Update: Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for fingolimod in the minimally invasive treatment of intracerebral hemorrhage (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Fingolimod (fingolimod)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Intracerebral Hemorrhage | Phase 1, Phase 2 | Status: UNKNOWN